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INTRODUCTION
Recently, preimplantation genetic diagnosis (PGD) has
been successfully applied as an alternative to prenatal diag-
nosis of chromosomal abnormalities and inherited diseases.
The procedures for PGD involve in vitro fertilization, embryo
culture, biopsy and analysis of the blastomere from preim-
plantation embryos using fluorescent in situ hybridization
(FISH) for chromosomal alterations or polymerase chain reac-
tion (PCR) for specific gene defects (1, 2). In case of PCR-
PGD, the minuscule amount of the DNA of a single blas-
tomere was faced with three major problems such as allele
drop-out (ADO), amplification failure and contamination (3,
4). Among them, amplification failure and contamination
could be solved by the optimization of PCR-PGD protocol. 
The ADO is a significant and unique problem which is
the failure of PCR to amplify one of the two alleles present
in the DNA sample. While it occurs occasionally, no method
has yet been developed to eliminate ADO in single cell anal-
ysis (5). The results by ADO may lead to misdiagnoses of
heterozygous embryos as homozygous affected or unaffected
embryos in PCR-PGD. Therefore, several strategies have been
developed to decrease ADO, such as increasing the denatu-
ration temperature and annealing time (6), using a more pow-
erful lysis method (7, 8), or applying the multiplex PCR and
fluorescent PCR for mutations or linked markers (9, 10).
The long-chain 3-hydroxyacyl CoA dehydrogenase (LCH-
AD) (EC 1.1.1.211) is a component of the tri-functional pro-
tein of the inner mitochondrial membrane with alpha and
beta subunits. The LCHAD deficiency is a fatal autosomal
recessive metabolic disorder and caused by mutation in the
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coen-
zyme A thiolase/enoyl-Coenzyme A hydratase (HADHA)
gene. Deficiency of this enzyme causes sudden unexplained
infant death, a Reye-like syndrome, cardiomyopathy, or skele-
tal myopathy. Patients with the LCHAD deficiency may also
develop long-term complications such as peripheral neuropa-
thy or pigmentary retinopathy leading to impaired vision.
The incidence of LCHAD deficiency in the general popula-
tion is approximately 1 in 70,000 (11, 12). In our pre-diag-
nostic test for a LCHAD deficiency case, unexpected genotyp-
ing results were observed from a female patient and her daugh-
ter DNA samples with a referred primer set. The problem
was settled by further genetic analysis with a re-designed
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Identification of a Novel Single Nucleotide Polymorphism of HADHA
Gene at a Referred Primer-binding Site During Pre-diagnostic Tests
for Preimplantation Genetic Diagnosis 
The pre-diagnostic test for preimplantation genetic diagnosis (PGD) of long-chain
3-hydroxyacyl-CoA dehydrogenase deficiency was performed by polymerase chain
reaction (PCR) and direct sequencing for hydroxyacyl-Coenzyme A dehydrogenase/
3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (HADHA) gene. We
obtained unexpected genotyping results of HADHA gene by allele drop-out in the
analysis of patients’ genomic DNA samples with a referred PCR primer set. Upon
further analysis with a re-designed primer set, we found a novel single nucleotide
polymorphism (SNP) at the referred primer-binding site in the normal allele of HADHA
gene (NT_022184, 5233296 a>t). We found that the frequency of this novel SNP
was 0.064 in Korean population. Pre-diagnostic test using single lymphocytes and
clinical PGD were successfully performed with the re-designed primer set. Nine-
teen embryos (95.0%) among 20 were successfully diagnosed to 5 homozygous
mutated, 8 heterozygous carrier and 6 wild type. Among 6 normal embryos, well
developed and selected 4 embryos were transferred into the mother’s uterus, but
a pregnancy was not achieved. We proposed that an unknown SNP at primer-bind-
ing sites would be a major cause of allele drop-out in the PGD for single gene dis-
order. 
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primer set for the HADHA gene. 
In this study, we described the process of identification of
a novel single nucleotide polymorphism (SNP) at a referred
primer-binding site during the pre-diagnostic test for PGD
of LCHAD deficiency. We found a novel SNP of the HADHA
gene and investigated the allele frequency in Korean popu-
lation.
MATERIALS AND METHODS
Patients
A couple (husband: 37 yr, wife: 33 yr) was referred to our
center after five neonatal deaths due to severe lactic acidemia
(Fig. 1). There was no significant abnormality in their med-
ical history and physical examination. Molecular genetic anal-
ysis of the couple’s HADHA gene was performed by PCR
and direct sequencing in Seoul Asan Hospital, and revealed
a single base substitution (IVS16+2 t>g) in the intron 16 of
HADHA gene resulting in total deletion of exon 16. Unfor-
tunately, these mis-splicing mutations were detected in all
family members. They are carriers for IVS16+2 t>g in the
HADHA gene. The couple requested PGD for a pregnancy
with an unaffected baby. 
Pre-diagnostic test for PCR-PGD
The pre-diagnostic test for PCR-PGD for the single gene
disorder was composed of two steps in our center. First step
was to confirm the reported genotyping with genomic DNA
from patients and normal relatives. Second step was to opti-
mize our protocol for single blastomere analysis using single
lymphocytes samples. Genomic DNA was extracted from 5
mL EDTA anti-coagulated blood samples using the AquaPure
Genomic DNA Isolation kit (Bio-Rad Laboratories, Hercules,
CA, U.S.A.) according to the manufacturer’s instructions.
We used two kinds of primer sets for the pre-diagnostic
test of LCHAD deficiency in this study. One was a referred
primer set (HADHA-E16), which was applied for screening
the mutation, at Seoul Asan Hospital. Another was a re-de-
signed primer set (HADHA-E16W, Table 1, Fig. 2) by our
center which amplified the outer region of the referred primer.
The DNA fragments from PCR were analyzed by the direct
DNA sequencing as described below.
Pre-diagnostic test using single lymphocytes
In order to determine the efficiency of single cell PCR and
ADO rates, the pre-diagnostic testing was performed with
single lymphocytes and the primers, which were used for the
detection of the causative mutation. Lymphocytes were iso-
lated from 10 mL of peripheral blood in heparinized tubes
collected from the female patient and her husband using Ficoll-
Paque density gradient separation (Ficoll-PaqueTMPLUS, Ame-
rsham Biosciences AB, Uppsala, Sweden) according to the
manufacturer’s protocol. The cell layer containing lympho-
cytes was removed and diluted with sterile and filtered phos-
phate-buffered saline (PBS) to adjust cell density for single
Fig. 1. Pedigree of the family having LCHAD deficiency. Father,
mother and their live daughter have both wild (W) and mutant (M)
allele of the HADHA gene. Father and mother have the same HA-
DHA gene mutation site (   ). Both mother and her daughter have
a normal allele with an unidentified SNP (   ).
Fig. 2. Schematic representation for a part of the HADHA gene,
together with the position of SNP and two pairs of primers used in
this study. PCR primer sets were designed from the 5′ and 3′ flank-
ing regions of the exon 16 in the HADHA gene. The right upper-
most is the sequences of reverse primer (E16-R) and two lowers
are the sequences of genomic DNA of wild and variant type alle-
les, respectively. The horizontal arrows indicate the direction and
the location of each primer and the vertical arrow indicates the
mutation loci (HADHA IVS16+2 t>g) in this family.
WM
WM WM
Exon 15 Exon 16 AG gttgg
5′ aagata t ggaccaagcttcc3′ (variant)
5′ aagata a ggaccaagcttcc3′ (wild type)
3′ ttctat t cctggttcgaagg5′ (HADHA E16 primer)
E16W-F E16W-R
E16-R E16-F
T*, single nucleotide polymorphism site A/T (NCBI refSNP ID: rs17549-
879).
Sequences (5′ →3′ )
Annealing
temp. 
(°C)
Pro-
duct
size 
(bp)
HADHA E16 F-ATGACTTTGAAGTGACCCTG 63 248
(referred primer) R-GGAAGCTTGGTCCT*TATCTT
HADHA E16W F-CTTCCCCTGCAATTTCATTT 64 365
(newly designed  R-CCAGGGACCTTCCTAGACAA
primer)
Table 1. Oligonucleotide sequences of the primers for HADHA
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cell isolation. Single lymphocytes were isolated using a fine
heat-polished glass micropipette and then loaded into 0.2 mL
thin wall PCR tubes containing 5  L of alkaline lysis buffer
(200 mM/L KOH and 50 mM/L dithiothreitol) under a stereo
microscope. The single lymphocyte samples were stored at
-20℃until analysis.
In vitro fertilization and blastomere biopsy procedure 
Controlled ovarian hyperstimulation was done as previously
described (1). Following ovarian stimulation, follicles were
aspirated and matured oocytes were fertilized by intracyto-
plasmic sperm injection (ICSI). Fertilized oocytes were cul-
tured in the G1.2 medium (Vitrolife Sweden AB, Kungs-
backa, Sweden) for three days. On the third day of culture,
embryos were incubated for 5 min in Ca2+/Mg2+-free medi-
um (EB-10TM, Vitrolife Sweden AB) before biopsy. The acid
Tyrode’s solution (ZD-10TM, Vitrolife Sweden AB) was applied
to create a small hole in the zona pellucida. Biopsy was per-
formed by gentle aspiration using a polished micropipette
with 30  m of inner diameter. One blastomere was biopsied
on embryos with less than 6-cells and two blastomeres on six
or more cells. After the blastomere biopsy procedure, embryos
were washed several times and transferred to the G2.2 medi-
um (Vitrolife Sweden AB). Each blastomere was washed twice
through two drops of G2.2 medium and transferred into ster-
ile 0.2 mL PCR tubes containing 5  L of alkaline lysis buffer.
For each biopsied blastomere, blank negative controls were
prepared from the washing drops. Embryos were cultured
under the standard culture condition until the diagnosis was
accomplished. Embryos with normal genotype were selected
and transferred into the mother’s uterus on the fourth day of
culture. 
Cell lysis and PCR procedure
The lymphocytes and blastomeres were prepared with alka-
line lysis buffer at 65℃ for 10 min incubation. The buffer
containing sample was neutralized by the addition of 5  L of
neutralization buffer (900 mM/L Tris-HCl, 300 mM/L KCl,
200 mM/L HCl) before proceeding to PCR. The PCR strat-
egy consisted of the first PCR followed by the hemi-nested
PCR for the mutation of the HADHA gene. After cell lysis
and neutralization, 1.5 mM/L MgCl2, 200  M/L of each dNTP
(Roche Diagnostics GmbH, Mannheim, Germany), 1 IU Su-
pertherm DNA polymerase (JMR HOLDINGS, London,
U.K.) and 0.5  M/L of each outer primers, were added to
each tube for a total volume of 30  L. The first round of PCR
involved a 96℃denaturation temperature for 10 min as a means
to reduce ADO, followed by 25 cycles consisting of 95℃for
40 sec, 62℃ for 1 min and 72℃ for 1 min, and followed
by a final extension step of 10 min at 72℃ on a GeneAmp
PCR System 2700 (Applied Biosystems, Foster City, CA,
U.S.A.). For the second round of DNA amplification, 1  L
of the first PCR reaction products was added to another tube
containing 2  L of PCR buffer (50 mM/L KCl, 10 mM/L Tris-
HCl, pH 8.3), 1.5 mM/L MgCl2, 200  M/L of each dNTP,
2 IU SynergyN DNA polymerase (GeneCraft Co, Munster,
Germany) and 0.5  M/L of each inner primer, and the ampli-
fication was performed with 40 cycles as described above. In
order to detect PCR products, 3  L of each PCR product was
subjected to electrophoresis in the 2% agarose gel.
Direct DNA sequence analysis
For DNA sequence analyses, the PCR products were puri-
fied by the purification kit (Qiagen GmbH, Hilden, Ger-
many). The purified PCR products (40 ng) were sequenced
by direct cycle sequencing using fluorescent-labelled dideoxy
terminators (Big Dye Terminator Cycle Sequencing Ready
Reaction Kit; Applied Biosystems, Foster City, CA, U.S.A.),
according to the manufacturer’s protocol. The reaction con-
ditions were as follows: 25 PCR cycles, a denaturation step
of 10 sec at 96℃, annealing for 5 sec at 50℃ and extension
for 4 min at 60℃ on a GeneAmp PCR System 2700 (Appli-
ed Biosystems). The samples were then cleared using ethanol
precipitation for unincorporated dye terminator removal. The
precipitated pellets were resuspended with 20  L of Hi-Di
Formamide (Applied Biosystems), denatured at 95℃ for 4
min and run on ABI Prism 3100 Avant automated genetic
analyzer (Applied Biosystems). The sequences were compared
with the wild type controls using Seqscape Software (Applied
Biosystems) for mutation analysis.
Population study for a novel SNP
To determine the frequency of a novel SNP of the HADHA
gene in the Korean population, genomic DNA samples from
unrelated individuals (n=63) were extracted, then analyzed
by PCR and direct sequencing as described above. This study
was approved by the Institutional Review Board (IRB) as
SCH-IRB-2004-01. Written consent was obtained from the
subjects in order to confirm that genomic DNA could be used
for research purposes.
RESULTS
Confirmation of the mutation site in the family
Before the clinical trial of PGD, we always confirm the
mutation site of parents and their children or relatives with
individual’s genomic DNA samples, and then perform the
single lymphocyte analysis. PCR amplification was carried
out with the referred primers, which were designed for genetic
screening at Seoul Asan Hospital, and then the DNA frag-
ments of PCR was carried out direct sequencing. However,
compared with previous reports from Seoul Asan Hospital,Novel SNP of HADHA Gene During Preimplantation Diagnosis 797
we observed different genotype of the HADHA gene in the
family. The male patient had a heterozygous genotype, the
same result (carrier of HADHA IVS16+2 t>g) as the previ-
ous reports. However, the female patient and her daughter
showed unexpected results. According to our results of PCR
with the referred primer (HADHA-E16), the female patient
and her daughter were not identified as heterozygous geno-
type, but homozygous for IVS16+2 t>g of the HADHA gene.
And then, we performed several independent PCR analyses
in different PCR conditions. However, we could not figure
out any problem with the referred primer set.
Identification of a novel SNP at the primer-binding site
To settle the problem, the unexpected genotyping of the
HADHA gene for the female patient and her daughter, DNA
samples were extracted again and primers were re-designed
to amplify a larger region containing HADHA-E16 primer-
binding sites (Table 1, Fig. 2). After the amplification with
the re-designed primer set (HADHA-E16W) and direct se-
quencing of PCR products, both patients and their daughter
were confirmed as heterozygotes for the mutated site.
As results of complete sequencing of both strands for PCR
products amplified with HADHA-E16W primers, a novel
SNP was found at the binding site of the referred reverse
primer for the HADHA gene. We registered the novel SNP
of the HADHA gene on the GenBank site (NT_022184,
5233296 a>t NCBI refSNP ID: rs17549879). The novel
SNP is located at the 7th position of the 3′ end of the referred
reverse primer sequences in only normal alleles of the female
patient and her daughter (Table 1, Fig. 3). However, the nor-
mal allele of the male patient had wild type sequence for this
site. This a/t polymorphism near the 3′ end of the referred
reverse primer was the very reason that the normal allele of
the female patient and her daughter was dropped out in the
PCR with the referred primer.
The frequency of the novel SNP in Korean population
We evaluated the frequency of the SNP in 63 unrelated
individuals from the Korean population. Eight individuals
(12.7%) were found to have this novel SNP as heterozygous
types. There was no homozygous type for this SNP in tested
samples. The SNP frequency of the HADAH gene in Kore-
an population was determined to be 0.064 by studying 126
chromosomes. This SNP was in Hardy-Weinberg equilibri-
um ( 2=0.290, df=1).
Pre-diagnostic test using single lymphocytes
The efficiency and accuracy of the single cell PCR analy-
sis was tested using single lymphocytes of peripheral blood
from the male and female patient with heterozygous geno-
type. PCR on single lymphocytes resulted in 95.9% (70/73)
amplification rate, whereas none of the negative controls show-
ed a band. The ADO of single lymphocytes PCR by direct
DNA sequencing was detected in 16 out of 70 lymphocytes
(22.9%) in the PCR and direct sequencing.
Outcome of preimplantation genetic diagnosis for LCHAD
deficiency
After ovarian hyperstimulation, a total of 25 oocytes were
retrieved and 20 matured oocytes (metaphase-II) were isem-
inated by ICSI, and then fertilized 20 embryos were diagnosed.
Two blastomeres were biopsied from 14 embryos and one
blastomere from 6 embryos, respectively. In the PCR and
direct sequencing, 33 blastomeres of 19 embryos among 34
blastomeres of 20 embryos were successfully amplified and
diagnosed. Amplification rate per blastomere and embryo
was 97.1% and 95.0%, respectively. There were no amplifi-
cations in all negative controls. The ADO of single cell PCR
was detected in 7 of 33 amplified samples (21.2%). Nineteen
embryos (95.0%) among 20 were successfully diagnosed to
5 homozygous mutated, 8 heterozygous carrier and 6 wild
type. Among 6 normal embryos, well developed and select-
ed 4 embryos were transferred into the mother’s uterus, but
a pregnancy was not achieved. 
Fig. 3. Sequencing results showing the region of the HADHA-E16 reverse primer-binding site harboring the novel SNP. Arrows indicate the
position of SNP. Male patient (A) was homozygous (A/A) whereas female patient (B) and her daughter (C) were identified as heterozygous
(A/T), respectively.
A A/A
AAG AT AAGGA CCAA
270
B A/T
AA G A TA N GGA CC AA
270
C A/T
AAG A T A NGG ACCAA
270798 H.-S. Lee, H.W. Choi, C.K. Lim, et al.
DISCUSSION
In this study, a novel SNP at the primer-binding site was
identified by PCR with a newly re-designed primer set and
direct sequencing. The frequency of this novel SNP was 0.064
in Korean population of this study. Although we have not
tested populations of other nations, any frequency above 0.01
is considered polymorphic in a population. We registered
this novel polymorphism at the GenBank as NT_022184,
5233296 a>t, NCBI refSNP ID: rs17549879. The novel
SNP might be a major cause of amplification failure of the
normal allele in the female patient and her daughter, thus
only mutated allele of the HADHA gene was amplified with
the referred primer in our stringent PCR condition of PGD.
In our pre-diagnostic test with genomic DNA samples, the
discrepancy of genotyping of the HADHA gene using the
referred primer set occurred between our center and another
mutation screening laboratory. We have discussed about this
problem several times hoping to find a solution. They used
a different Taq. polymerase and PCR protocols from our high
stringent PCR condition for PGD, which was important to
prevent the generation of non-specific PCR products. Our
laboratory has endeavored to optimize single cell PCR con-
ditions for PGD including longer initial denaturation time,
higher denaturation temperature, a specific Taq polymerase,
adjust of MgCl2 concentration and alkaline lysis methods (8).
Several independent PCR analyses were tried using genomic
DNA samples by our stringent PCR condition, however,
we could not figure out the problem with the referred primer
set. Upon further genetic analysis with a re-designed primer
set, we found a novel SNP of the HADHA gene at the bind-
ing site of the referred primer in the normal allele of the female
patient and her daughter. With the re-designed primer set,
pre-diagnostic tests in single lymphocytes and clinical PGD
trial were successfully done.
Most researchers for PGD make an effort to optimize the
PCR conditions with single cell samples. In this respect, our
study shows the importance of thoroughly characterizing the
performance of primer sets prior to changing amplification
conditions or DNA polymerases. The distinct genotyping
for a mutation in a single gene disorder, especially autosomal
dominant disorder, could be inconsistent with the expected
results. When this situation occurs, the possibility of SNP
at the primer-binding site should be speculated. Although
none of the subjects in this study carried SNP on the mutant
allele, if SNP was on the mutant allele, the mutant allele could
be dropped-out. The presence of the unidentified SNP may
lead to incorrect genotyping and potential misdiagnosis in
clinical PGD cases. Therefore, it is very important to test a
significant number of individuals with used primers to evalu-
ate the SNP in the primer binding sites. Several reports show-
ed the potential error in molecular diagnosis from unidenti-
fied SNPs and mutations like this study (13-16). 
In conclusion, we report the successful PGD in a couple
at risk of transmitting the LCHAD deficiency, although no
pregnancy resulted. As far as we know, this is the second report
in the world and the first report in Korea that successful PGD
for LCHAD deficiency case (17). We identified the novel SNP
of the HADHA gene in the referred primer-binding site, and
it was the major cause of ADO for the normal allele in the
pre-diagnostic tests for PGD of LCHAD deficiency. We pro-
posed that an unknown SNP at primer-binding sites would
be a major cause of allele drop-out in the PGD for single gene
disorder. 
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